The Personalized Medicine Coalition announced today that Carl June, MD, the Richard W. Vague Professor in Immunotherapy and Director, Center for Cellular Immunotherapies, is the recipient of its 16th Annual Leadership in Personalized Medicine Award. The award recognizes the promise of a new era in precision medicine with treatments characterized by ability to alter molecular characteristics of patients’ own cells. Dr. June's nomination letters notes that his research with chimeric antigen receptor (CAR) T-cells over the course of three decades has unlocked an entirely new approach to cancer care by demonstrating that a patient’s own immune cells can be genetically modified to seek and attack cancer cells.

Read the PMC press release.